Lenalidomide after Stem-Cell Transplantation for Multiple MyelomaPhilip L. McCarthy, Charles Linker, Kouros Owzar et al.|New England Journal of Medicine|2012Cited by 1.1k
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaFaith E. Davies, Kenneth C. Anderson, Boris K. Lin et al.|Blood|2001Cited by 905
Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Susanna Jacobus et al.|New England Journal of Medicine|2022Cited by 457